chr1-44826501-G-A

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_003738.5(PTCH2):​c.2963C>T​(p.Thr988Met) variant causes a missense change. The variant allele was found at a frequency of 0.0299 in 1,613,816 control chromosomes in the GnomAD database, including 1,433 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Synonymous variant affecting the same amino acid position (i.e. T988T) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.029 ( 187 hom., cov: 32)
Exomes 𝑓: 0.030 ( 1246 hom. )

Consequence

PTCH2
NM_003738.5 missense

Scores

6
12

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: 3.89

Publications

24 publications found
Variant links:
Genes affected
PTCH2 (HGNC:9586): (patched 2) This gene encodes a transmembrane receptor of the patched gene family. The encoded protein may function as a tumor suppressor in the hedgehog signaling pathway. Alterations in this gene have been associated with nevoid basal cell carcinoma syndrome, basal cell carcinoma, medulloblastoma, and susceptibility to congenital macrostomia. Alternatively spliced transcript variants have been described.[provided by RefSeq, Oct 2009]
PTCH2 Gene-Disease associations (from GenCC):
  • nevoid basal cell carcinoma syndrome
    Inheritance: AD, Unknown Classification: MODERATE, SUPPORTIVE, LIMITED Submitted by: Genomics England PanelApp, ClinGen, Labcorp Genetics (formerly Invitae), Orphanet
  • commissural facial cleft
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0020764172).
BP6
Variant 1-44826501-G-A is Benign according to our data. Variant chr1-44826501-G-A is described in ClinVar as Benign. ClinVar VariationId is 415448.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.155 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PTCH2NM_003738.5 linkc.2963C>T p.Thr988Met missense_variant Exon 18 of 22 ENST00000372192.4 NP_003729.3 Q9Y6C5-1
PTCH2NM_001166292.2 linkc.2963C>T p.Thr988Met missense_variant Exon 18 of 23 NP_001159764.1 Q9Y6C5-2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PTCH2ENST00000372192.4 linkc.2963C>T p.Thr988Met missense_variant Exon 18 of 22 1 NM_003738.5 ENSP00000361266.3 Q9Y6C5-1
PTCH2ENST00000447098.7 linkc.2963C>T p.Thr988Met missense_variant Exon 18 of 23 1 ENSP00000389703.2 Q9Y6C5-2

Frequencies

GnomAD3 genomes
AF:
0.0290
AC:
4406
AN:
152152
Hom.:
189
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00555
Gnomad AMI
AF:
0.00219
Gnomad AMR
AF:
0.0598
Gnomad ASJ
AF:
0.0170
Gnomad EAS
AF:
0.163
Gnomad SAS
AF:
0.0642
Gnomad FIN
AF:
0.0444
Gnomad MID
AF:
0.0222
Gnomad NFE
AF:
0.0221
Gnomad OTH
AF:
0.0311
GnomAD2 exomes
AF:
0.0468
AC:
11675
AN:
249552
AF XY:
0.0449
show subpopulations
Gnomad AFR exome
AF:
0.00502
Gnomad AMR exome
AF:
0.0844
Gnomad ASJ exome
AF:
0.0247
Gnomad EAS exome
AF:
0.165
Gnomad FIN exome
AF:
0.0463
Gnomad NFE exome
AF:
0.0210
Gnomad OTH exome
AF:
0.0357
GnomAD4 exome
AF:
0.0300
AC:
43779
AN:
1461546
Hom.:
1246
Cov.:
34
AF XY:
0.0304
AC XY:
22130
AN XY:
727102
show subpopulations
African (AFR)
AF:
0.00460
AC:
154
AN:
33480
American (AMR)
AF:
0.0835
AC:
3733
AN:
44690
Ashkenazi Jewish (ASJ)
AF:
0.0237
AC:
620
AN:
26136
East Asian (EAS)
AF:
0.152
AC:
6040
AN:
39696
South Asian (SAS)
AF:
0.0595
AC:
5132
AN:
86252
European-Finnish (FIN)
AF:
0.0470
AC:
2502
AN:
53184
Middle Eastern (MID)
AF:
0.0304
AC:
175
AN:
5754
European-Non Finnish (NFE)
AF:
0.0208
AC:
23179
AN:
1111960
Other (OTH)
AF:
0.0372
AC:
2244
AN:
60394
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.480
Heterozygous variant carriers
0
2868
5737
8605
11474
14342
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
1010
2020
3030
4040
5050
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0290
AC:
4419
AN:
152270
Hom.:
187
Cov.:
32
AF XY:
0.0315
AC XY:
2343
AN XY:
74444
show subpopulations
African (AFR)
AF:
0.00553
AC:
230
AN:
41554
American (AMR)
AF:
0.0601
AC:
920
AN:
15300
Ashkenazi Jewish (ASJ)
AF:
0.0170
AC:
59
AN:
3470
East Asian (EAS)
AF:
0.164
AC:
847
AN:
5176
South Asian (SAS)
AF:
0.0643
AC:
310
AN:
4822
European-Finnish (FIN)
AF:
0.0444
AC:
471
AN:
10614
Middle Eastern (MID)
AF:
0.0238
AC:
7
AN:
294
European-Non Finnish (NFE)
AF:
0.0221
AC:
1500
AN:
68016
Other (OTH)
AF:
0.0346
AC:
73
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
204
408
611
815
1019
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
58
116
174
232
290
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0253
Hom.:
384
Bravo
AF:
0.0286
TwinsUK
AF:
0.0167
AC:
62
ALSPAC
AF:
0.0192
AC:
74
ESP6500AA
AF:
0.00704
AC:
31
ESP6500EA
AF:
0.0207
AC:
178
ExAC
AF:
0.0436
AC:
5295
Asia WGS
AF:
0.102
AC:
355
AN:
3478
EpiCase
AF:
0.0210
EpiControl
AF:
0.0176

ClinVar

Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Apr 04, 2019
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Basal cell carcinoma, susceptibility to, 1 Benign:1
Jul 07, 2023
KCCC/NGS Laboratory, Kuwait Cancer Control Center
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Gorlin syndrome Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Basal cell nevus syndrome 1 Benign:1
Feb 01, 2025
KCCC/NGS Laboratory, Kuwait Cancer Control Center
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.060
BayesDel_addAF
Benign
-0.50
T
BayesDel_noAF
Benign
-0.35
CADD
Benign
22
DANN
Uncertain
0.99
DEOGEN2
Uncertain
0.50
.;T
Eigen
Benign
-0.069
Eigen_PC
Benign
-0.14
FATHMM_MKL
Uncertain
0.82
D
LIST_S2
Benign
0.85
D;T
MetaRNN
Benign
0.0021
T;T
MetaSVM
Benign
-0.76
T
MutationAssessor
Uncertain
2.3
M;M
PhyloP100
3.9
PrimateAI
Uncertain
0.50
T
PROVEAN
Benign
-2.1
N;N
REVEL
Uncertain
0.38
Sift
Benign
0.031
D;D
Sift4G
Benign
0.093
T;T
Polyphen
0.84
P;P
Vest4
0.20
MPC
0.19
ClinPred
0.027
T
GERP RS
0.35
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.091
gMVP
0.79
Mutation Taster
=93/7
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs11573590; hg19: chr1-45292173; COSMIC: COSV64709904; COSMIC: COSV64709904; API